Keyphrases
Clinical Practice Guidelines
100%
Social Security
85%
Peruvian
66%
Peru
59%
Good Clinical Practice
41%
Assessment Development
37%
Evaluation Assessment
37%
Evaluation Method
37%
Grading of Recommendations
37%
Development Methodology
37%
Assessment Methodology
37%
Guideline Development Group
35%
PubMed
22%
Evidence-based
22%
Clinical Practice Guide
22%
Methodologists
20%
In-hospital Mortality
20%
Clinical Recommendations
17%
ANCA-negative
16%
People Living with Human Immunodeficiency Virus
16%
XDR Pseudomonas Aeruginosa
16%
Diagnosis Management
16%
Severe Aortic Stenosis
16%
Initial Management
16%
Ischemic Cerebrovascular Accident
16%
COVID-19 Pneumonia
16%
Hepatitis-viral
16%
Acute Stage
16%
Acinetobacter Infections
16%
Fecal Microbiota Transplantation
16%
Terlipressin
16%
Early-stage Cervical Cancer
16%
Infection-related
16%
Hemodialysis Access
16%
Infection Management
16%
Vasopressin
16%
Acute Variceal Bleeding
16%
Acinetobacter
16%
Hypertrophic Pachymeningitis
16%
Third Level
16%
Infection Prevention
16%
Adult Patients
16%
Pseudomonas
16%
Rheumatoid Arthritis
16%
Extensively Drug-resistant
16%
Patient Assessment
16%
Colistin
16%
Scoping Review
16%
Meta-analysis
16%
Granulomatosis with Polyangiitis
16%
Medicine and Dentistry
Infection
45%
Social Health
33%
Methodologist
20%
Hospital Mortality
20%
Fecal Microbiota Transplantation
16%
Acinetobacter
16%
Pseudomonas aeruginosa
16%
Cervical Cancer
16%
Acinetobacter Infection
16%
Pseudomonas
16%
Hepatitis Virus
16%
Apoplexy
16%
Hemodialysis
16%
Rheumatoid Arthritis
16%
COVID-19
16%
Colistimethate
16%
Human Immunodeficiency Virus
16%
Retrospective Cohort Study
16%
Inflammatory Arthritis
16%
Systematic Review
15%
Oxygen Consumption
8%
Adverse Event
5%
Clinical Trial
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
45%
Pseudomonas aeruginosa
22%
Hospital Mortality
20%
Cohort Study
16%
Cerebrovascular Accident
16%
Uterine Cervix Cancer
16%
Hemodialysis
16%
Virus Hepatitis
16%
Carbapenemase
16%
Rheumatoid Arthritis
16%
Aortic Stenosis
16%
Colistimethate
16%
Pseudomonas
16%
Acinetobacter
16%
Acinetobacter Infection
16%
Feces microflora
16%
HIV
16%
Inflammatory Arthritis
16%
Vasopressin
16%
Enterobacteriaceae
8%
Adverse Event
5%
Clinical Trial
5%
Penicillinase
5%
